MedTrace Logo

Delta qSOFA for Risk Stratification in Emergency Infected Patients

NCT02926664 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 512

Last updated 2017-10-24

No results posted yet for this study

Summary

The study will investigate the prognostic value of qSOFA (quick Sequential Organ Failure Assessment) kinetics between H0 and H1, and between H0 and H3 in patients with suspicion of Sepsis, i.e. an initial qSOFA of at least of 2.

Conditions

Interventions

OTHER

measurement of qSOFA

qSOFA will be measured at H0, H1 and H3

Sponsors & Collaborators

  • Societe Française de Medecine d'urgence

    lead OTHER

Principal Investigators

  • Yonathan Freund · Emergency Department - hopital pitie salpetriere, Paris, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-05-01
Completion
2017-05-01

Countries

  • Belgium
  • France
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02926664 on ClinicalTrials.gov